圆素品牌怎么样 申请店铺

包头东宝生物技术股份有限公司成立于1997年，是一家专业的生物制品国家级高新技术企业。主营“金鹿”牌明胶、“圆素”牌胶原蛋白及“白云”牌磷酸氢钙产品。公司注册资本近2亿元，拥有总资产约5亿元。

公司2011年7月6日在深圳证券交易所成功上市，股票简称“东宝生物”，股票代码“300239”，是内蒙古自治区第一家在创业板上市的民营企业，也是包头市第一家登陆国内A股的民营企业。

公司技术中心早在2001年就被认定为自治区级技术中心。公司通过了ISO9001国际质量体系认证、HACCP食品安全管理体系认证。2010年东宝生物获中国日用化工协会明胶分会颁发2005-2009年度全国明胶行业先进企业荣誉;2010年获国家发改委授予“国家高技术产业化示范工程”牌匾;2012年,可溶性胶原蛋白研发及产业化项目获内蒙经信委颁发自治区乌兰夫基金企业技术创新奖;2012年，公司获第一财经中国资本力年会颁发年度最佳融资范例奖、年度最佳创业板IPO上市公司荣誉；2013年，获内蒙质监局、内蒙出入境检验检疫局、内蒙药监局等16家单位联合颁发的内蒙古“2012年全国质量月产品质量用户满意度调查用户满意单位”荣誉证书。2013年获内蒙党委、政府认定为内蒙古自治区非公有制科学发展先进企业。

2010年，东宝生物与中科院理化所历时两年多时间共同开发出千位级道尔顿“圆素”牌小分子量骨胶原蛋白肽，生产技术获中国发明专利（专利号：ZL200910241882.X）。“圆素”牌胶原蛋白肽产品经SGS国际权威机构检测，平均分子量约在1300道尔顿，产品质量指标达到国际同类产品先进水平，属高品质胶原蛋白产品。系列粉剂、果汁饮品、面膜、眼膜、眼霜等产品上市以来，以其过硬的产品质量赢得了国际、国内消费者和下游客户的广泛认可和赞誉。升级后的新包装以及VI新形象品味独特，健康和美丽蕴含其间，品牌效应逐步显现。公司目前生产的胶原蛋白产品及在研的后续产品符合国家最新发布的《关于促进健康服务业发展的若干意见》和《中国食物与营养发展纲要（2014—2020年）》支持方向，具有良好的发展前景。

公司拥有行业内首家产学研合作研发机构——“中科院理化所—东宝生物胶原与明胶生物工程应用研发中心”，技术力量雄厚。已经开始的《不同分子量胶原蛋白肽促骨生长活性研究》、《基于静电纺丝技术明胶纳米纤维无纺布的制备及用途研究》、《600吨/年骨素酶法明胶生产中试线的工艺研究项目》等项目进展顺利，将对拓展企业主营业务、提升核心竞争力产生积极提升和推进作用。

2012年12月，公司以自有资金1000万元出资的全资子公司东宝圆素（北京）科贸有限责任公司成立。该公司主要负责胶原蛋白系列产品全国范围内的销售。

2013年10月，公司在内蒙古自治区政府统一安排部署下，在美国洛杉矶“中美省州经贸合作研讨会”上与美国的LipondInternational和Pureorg公司签订了战略合作框架合约。在此基础上，2013年12月东宝生物与LipondInternational在中国包头又签订了《原材料采购合约》，与Pureorg公司签订了《服务合作协议书》，通过pureorg同UCLA(加州大学洛杉矶分校）进行胶原蛋白及胶原蛋白衍生品对抑制肿瘤的研究，并研发相应复合型配方胶原蛋白产品，开启了“圆素”牌胶原蛋白大步走向国际市场的新局面。

据相关媒体分析，未来我国胶原蛋白年需求量有望达到2万吨，市场空间有望进一步加速放大，市场前景十分广阔。

公司作为新兴生物制品企业，主营业务符合国家促进生物产业、战略性新兴产业等政策扶持方向，属国家重点支持的行业。良好的政策环境为企业实现快速发展创造了前所未有的条件。公司地处内蒙古，拥有丰富的骨料资源，立足高档生物制品的专业化生产，借助资本市场的融资手段，打造稳健发展、持续增长的生物制品企业，为我国生物产业做出新的贡献，为人类对健康和美的追求作出最大的贡献。

Baotou Dongbao Biotechnology Co., Ltd., founded in 1997, is a professional national high-tech enterprise of biological products. Main products are "Jinlu" brand gelatin, "Yuansu" brand collagen and "Baiyun" brand calcium hydrogen phosphate products. The company has a registered capital of nearly 200 million yuan and a total asset of about 500 million yuan. The company was successfully listed in Shenzhen Stock Exchange on July 6, 2011. The stock is called "Dongbao biology" for short, with the stock code of "300239". It is the first private enterprise listed on the growth enterprise market in Inner Mongolia Autonomous Region, and the first private enterprise listed on the domestic A-share market in Baotou city. As early as 2001, the company's technology center was recognized as an autonomous region level technology center. The company has passed ISO9001 international quality system certification and HACCP food safety management system certification. In 2010, Dongbao biology was awarded the honor of 2005-2009 national advanced enterprise in gelatin industry by gelatin branch of China Daily Chemical Industry Association; in 2010, Dongbao biology was awarded the plaque of "national high technology industrialization demonstration project" by national development and Reform Commission; in 2012, soluble collagen R & D and industrialization project was awarded the technology innovation award of WuLanfu fund enterprise by Inner Mongolia Economic and Information Commission; In 2012, the company won the annual best financing example award and the annual best gem IPO listed company honor issued by China capital power annual meeting of first finance and economics; in 2013, the company won the Inner Mongolia "2012 national quality month product quality customer satisfaction survey user satisfaction unit" honorary certificate jointly issued by Inner Mongolia Quality Supervision Bureau, Inner Mongolia entry exit inspection and Quarantine Bureau, Inner Mongolia Drug Administration and other 16 units. In 2013, it was recognized by the Party committee and the government of Inner Mongolia as an advanced enterprise of non-public scientific development in Inner Mongolia Autonomous Region. In 2010, it took more than two years for Dongbao biology and Institute of physics and chemistry of Chinese Academy of Sciences to jointly develop thousands of Dalton "Yuansu" brand small molecular weight bone collagen peptide, and the production technology was patented in China (Patent No.: zl200910241882. X). "Yuansu" brand collagen peptide products have been tested by SGS international authority. The average molecular weight is about 1300 Dalton. The product quality index has reached the international advanced level of similar products. It is a high-quality collagen product. Products such as series of powder, juice drinks, facial mask, eye mask and eye cream have been widely recognized and praised by international and domestic consumers and downstream customers for their excellent product quality. After upgrading, the new packaging and VI image taste are unique, health and beauty are contained in them, and the brand effect gradually appears. The company's current collagen products and follow-up products under research are in line with the support direction of several opinions on promoting the development of health service industry and China's food and Nutrition Development Program (2014-2020), which are newly released by the state, and have a good development prospect. The company has the first industry university research cooperation R & D institution in the industry - "Institute of physics and chemistry of Chinese Academy of Sciences - Dongbao biological collagen and gelatin bioengineering application R & D center", with strong technical force. The projects such as research on bone growth promoting activity of different molecular weight collagen peptide, research on the preparation and application of Gelatin Nanofiber non-woven fabric based on electrostatic spinning technology, and Research on the process of 600 t / a bone enzyme gelatin production pilot line are progressing smoothly, which will play an active role in expanding the main business and promoting the core competitiveness of the enterprise. In December 2012, Dongbao Yuansu (Beijing) science and Trade Co., Ltd., a wholly-owned subsidiary of the company with its own capital of 10 million yuan, was established. The company is mainly responsible for the nationwide sales of collagen products. In October 2013, under the unified arrangement and deployment of Inner Mongolia Autonomous Region government, the company signed a strategic cooperation framework contract with lipond international and pureorg company of the United States at the "Sino US provincial economic and trade cooperation seminar" in Los Angeles. On this basis, in December 2013, Dongbao biology and lipond international signed a raw material purchase contract in Baotou, China, and a service cooperation agreement with pureorg company. Through pureorg and UCLA, they carried out research on the inhibition of tumor by collagen and collagen derivatives, and developed corresponding compound collagen products, It has opened a new situation that "Yuansu" brand collagen strides to the international market. According to the analysis of relevant media, the annual demand for collagen in China is expected to reach 20000 tons in the future, the market space is expected to further accelerate the expansion, and the market prospect is very broad. As a new biological product enterprise, the main business of the company is in line with the national policy support direction of promoting biological industry and strategic emerging industry, and it is a key industry supported by the state. A good policy environment has created unprecedented conditions for the rapid development of enterprises. The company is located in Inner Mongolia, with rich aggregate resources, based on the specialized production of high-end biological products, with the help of financing means of capital market, to build a stable development and sustainable growth of biological products enterprises, to make new contributions to China's biological industry, and to make the greatest contribution to the pursuit of health and beauty.

本文链接： https://brand.waitui.com/d2cd7a313.html 联系电话：04726208635